Medically reviewed by Dr Zeeshan Afzal (MBBS, General Practitioner) — Medical Content Reviewer, Welzo.
Written by: The Welzo Longevity Editorial Team | Last updated: July 2026
Declared interest: Welzo sells sodium butyrate supplements. We have written this comparison on the evidence rather than on what we stock, and where the strongest "tributyrin is better" claims come from a company selling tributyrin, we say so. See our editorial policy.
The butyrate supplement market has settled into a straightforward marketing argument: sodium butyrate is the old form that gets absorbed too early and smells appalling, while tributyrin is the clever new form that survives digestion and reaches the colon.
Most of that argument is pharmacologically reasonable. What is missing is evidence that it translates into anything you would notice — the same standard we apply throughout our longevity supplements guide and across the anti-ageing and longevity supplements range.
It is the same question we put to NAD⁺ precursors in NMN benefits, side effects and dosage, the NMN supplements range and NMN Pro 1000: does a delivery improvement change an outcome? See the longevity stack guide for where compounds like these sit in a routine.
There is also a more awkward question that neither side of the butyrate debate raises, which is whether either form beats simply eating more fibre.
The short answer
Tributyrin has the better delivery argument and is far more tolerable. A large proportion of oral sodium butyrate is absorbed in the upper gastrointestinal tract before reaching the colon, which is why it is often sold enteric-coated [1]. But the evidence for tributyrin's superiority is thin. The comparative data comes substantially from an animal study in poultry, and the main human data — 32 adults, 300 mg tributyrin for 21 days — produced microbiome changes that were not statistically significant versus placebo, measured no clinical outcomes at all, and was published as a conference poster abstract rather than a full peer-reviewed paper [1,3]. Meanwhile most UK adults eat about 20 g of fibre against a 30 g target [2], and fibre is what your gut bacteria ferment into butyrate, in the colon, continuously. Fix that first.
Table of contents
Butyrate is a short-chain fatty acid produced when gut bacteria ferment dietary fibre in the colon. It is not primarily something you eat — it is something your microbiome manufactures on site, from the material you give it.
Its importance is not disputed. Butyrate is the preferred fuel for colonocytes, the cells lining the colon, which derive a large share of their energy from it directly rather than from circulating glucose. It is also involved in maintaining gut barrier integrity, modulating inflammation and regulating immune activity.
That biology is why "postbiotic" butyrate supplements exist. The reasoning runs: butyrate is good, some people may not produce enough, so take it directly. The reasoning is coherent. The execution is where it gets complicated.
The postbiotic argument assumes that a metabolite delivered as a capsule is interchangeable with the same metabolite produced continuously by bacteria at the site where it acts. That is an assumption, not an established fact, and it applies to this entire product category.
There is a reasonable counter-argument. In the colon, butyrate is generated steadily throughout the day by fermentation, in direct contact with the cells that consume it, alongside acetate and propionate and everything else fermentation produces. A once-daily capsule delivering a bolus of a single short-chain fatty acid to an uncertain location is a meaningfully different exposure.
It might still help. But the burden of proof sits with the product, and — as the trials below show — that burden has not yet been discharged.
Here is the engineering challenge that defines this entire comparison.
Butyrate is needed in the colon — the far end of the digestive tract. But butyrate and its salts are readily absorbed in the upper gastrointestinal tract. Swallow plain sodium butyrate and a large proportion is taken up long before it arrives anywhere useful [1].
This is the opposite of the usual supplement problem. Most compounds struggle to be absorbed at all. Butyrate is absorbed too easily, too early, in the wrong place.
Every butyrate product on the market is an attempt to solve that: enteric coatings, microencapsulation, slow-release matrices, or a chemically different form that resists early release. Tributyrin belongs to the last category.
Worth holding on to: a delivery innovation is only valuable if the payload does something once it arrives. Improving the pharmacokinetics of a compound that has not demonstrated clinical benefit improves the pharmacokinetics, not your health. This is the same distinction we drew about liposomal and sublingual formats in why supplements are expensive.
Sodium butyrate is butyric acid paired with sodium. It is the cheaper, longer-established and more widely available option, and it is what Welzo currently stocks.
Tributyrin is a triglyceride: a glycerol backbone with three butyrate molecules attached. It is the form of butyrate that occurs naturally in butter [1].
Because the butyrate is esterified rather than free, tributyrin behaves like a dietary fat rather than a salt. The proposal is that it passes the stomach and upper intestine relatively intact, is broken down further along by pancreatic lipase, and therefore releases butyrate closer to where it is needed. It also has far less odour, because the butyric acid is bound rather than free.
That is a genuinely sensible piece of formulation chemistry. If you were designing a butyrate delivery system from scratch, you might well arrive here.
The most emphatic "tributyrin is superior" material online — including detailed technical comparisons stating that tributyrin is the best form of butyrate because it reaches the colon — is published by ingredient suppliers who manufacture and sell tributyrin [4].
That does not make the chemistry wrong. It does mean the comparison is not disinterested, and it should be weighted the same way we weighted competitor-funded NMN testing in is NMN a scam? and industry-funded collagen trials in supporting skin ageing from the inside.
According to ConsumerLab's independent review, the preliminary evidence that tributyrate may have more beneficial intestinal effects than sodium butyrate comes from an animal study — specifically, research published in a poultry science journal — with more research in people needed to confirm it [1].
We are not dismissing animal work. But "the better form" is a strong claim to build on chicken data, and it is being made on product pages aimed at humans.
The debate is usually framed as two options, but calcium and magnesium butyrate are widely sold and appear in blended products — including the BodyBio product Welzo stocks, which combines butyrate with magnesium and calcium.
These behave broadly like sodium butyrate in terms of the early-absorption problem, with two practical differences: no added sodium, which matters if you are managing blood pressure, and the mineral itself contributes a small amount to your intake. Neither changes the fundamental delivery question, and neither has meaningfully better human evidence.
| Sodium butyrate | Tributyrin | |
|---|---|---|
| Chemical form | Salt of butyric acid | Triglyceride — three butyrates on glycerol |
| Natural occurrence | Not a natural dietary form | The form found in butter [1] |
| Absorption site | Largely upper GI tract [1] | Proposed release further along |
| Reaches colon | Limited unless enteric-coated [1] | Theoretically better; not demonstrated in humans |
| Odour and tolerability | Strong, unpleasant; a real adherence problem | Substantially better |
| Cost | Lower | Higher |
| Human evidence | More studies, mixed and often negative results [1] | Very limited; main human data is a poster abstract with a non-significant result [1,3] |
| Comparative evidence | Largely animal data, from a poultry study [1] | |
Set aside the form debate for a moment. Does butyrate supplementation in any form do much?
A pilot study of 32 men and women, average age 29, gave 300 mg of tributyrin for 21 days. It modestly altered the ratio of certain potentially beneficial bacteria and butyrate-producing bacteria in stool — but these changes were not statistically significant compared with placebo, and the study measured no clinical outcomes whatsoever [1].
There is a further detail worth knowing, because it is routinely omitted from product pages citing this work. It was presented as a poster abstract at a conference and published in a journal supplement, not as a full peer-reviewed research paper [3]. Abstracts are not subject to the same review as full papers, and they report results in a few hundred words without the methods detail needed to appraise them properly.
So the flagship human evidence for tributyrin is a null result, on a surrogate endpoint, in a conference abstract.
An Italian study of 46 overweight or obese adults following a low-calorie diet gave 625 mg of sodium butyrate three times daily — 1,875 mg per day — for 12 weeks. It did not produce greater fat loss than placebo [1].
That is a reasonably sized trial at a substantial dose over a meaningful period, and it found nothing.
Two small studies suggest butyrate may reduce pain and urgency of bowel movements, and may reduce abdominal pain and bloating in some people with IBS — with the reviewers noting that larger, better-designed studies are needed to prove a benefit [1].
This is where butyrate looks most plausible, and notably it is a clinical application in people with a diagnosed condition, not a healthy-ageing intervention. That distinction runs through this whole category — see longevity supplements that probably don't work.
Both forms exist to solve the problem of getting butyrate into the colon. Your gut bacteria solve that problem effortlessly, continuously, and for free — provided you feed them.
NHS guidance sets dietary fibre intake at 30 g a day for adults, and notes that most adults are only eating around 20 g, with evidence that eating plenty of fibre is associated with lower risk of heart disease, stroke, type 2 diabetes and bowel cancer [2]. The British Heart Foundation puts the average nearer 17 g against the same 30 g target [5].
So the typical UK adult has a 10 g daily fibre gap — a gap directly upstream of the compound they are considering buying in capsule form.
If you want to increase fibre rather than swallow the end product, see the Welzo fibre supplements, psyllium husk, inulin and prebiotics ranges — though food sources come first. Increase gradually and with plenty of fluid, since a sudden jump causes bloating and wind.
| Question | Sodium butyrate | Tributyrin |
|---|---|---|
| Doses used in research | Up to 1,875 mg/day in the obesity trial [1] | 300 mg/day in the microbiome pilot [1,3] |
| Typical product strength | 500–600 mg per capsule | Varies widely |
| With food? | Usually taken with or after a meal | With food, as it behaves like a fat |
| Formulation to prefer | Enteric-coated or microencapsulated [1] | Standard, given the ester structure |
| Realistic timeline | Weeks to months; see how long supplements take to work | |
Welzo currently stocks sodium butyrate options:
| Product | Notes |
|---|---|
| BodyBio Butyrate (Sodium), 60 capsules | From £25.01, with multi-buy discounts down to £22.51 for four or more. Includes magnesium and calcium alongside sodium butyrate. |
| Allnutrition Sodium Butyrate, 100 capsules | Positioned for dietary management in IBS and gut flora disorders — the application with the most supportive evidence [1]. Note: gelatin capsule shell, so not suitable for vegans. |
Broader gut health options: gut health, probiotics, Akkermansia, Ultra Purity L-Glutamine and digestive enzymes. Related reading: butyrate supplements in the UK, Akkermansia UK guide, glutamine vs collagen for gut health and modified citrus pectin.
Speak to your GP or pharmacist before starting butyrate in any form if you have inflammatory bowel disease, are on a sodium-restricted diet or managing blood pressure, take prescription medication, or are pregnant or breastfeeding.
See a doctor rather than self-treating if you have persistent changes in bowel habit, blood in your stool, unexplained weight loss, persistent abdominal pain, or symptoms that are new and have lasted more than a few weeks. These require assessment, and a supplement is not the appropriate first response. Bowel symptoms are one area where prompt clinical review genuinely matters.
On delivery theory and tolerability, probably yes — it resists early absorption and has far less odour. On evidence, the case is weak: the comparative data comes substantially from an animal study in poultry, and the main human tributyrin data (32 adults, 300 mg, 21 days) found microbiome changes that were not statistically significant versus placebo, measured no clinical outcomes, and was published as a conference poster abstract rather than a full paper [1,3]. Better theory, not demonstrated superiority.
Butyric acid is the compound responsible for the smell of rancid butter and vomit. In salt form the acid is relatively free to volatilise, so uncoated capsules smell strongly and it lingers. Tributyrin binds butyrate into a triglyceride, which largely solves the problem. Enteric coating also helps considerably with salt forms.
The biology is not in doubt — butyrate fuels colon cells and supports barrier function. Whether supplementing it helps is less clear. The most encouraging human evidence is in IBS, where two small studies suggest reduced pain, urgency and bloating in some people, with reviewers calling for larger and better-designed trials [1]. For general gut health in well people, the evidence is thin.
That is arguably the better strategy. Butyrate is produced by gut bacteria fermenting fibre in the colon — exactly where it is needed, continuously, with no delivery problem to solve. NHS guidance recommends 30 g of fibre daily while most adults manage around 20 g [2], so most people have a substantial gap upstream of the supplement they are considering.
Research doses vary widely by form: the sodium butyrate obesity trial used 1,875 mg per day, while the tributyrin microbiome pilot used 300 mg per day [1,3]. There is no established optimal dose because there is no established benefit to optimise for. Follow product directions and take it with food.
The available evidence says no. A study of 46 overweight or obese adults on a low-calorie diet taking 1,875 mg of sodium butyrate daily for 12 weeks found no greater fat loss than placebo [1]. Any product marketed for weight loss on the basis of butyrate is going beyond the evidence.
No. Probiotics are live bacteria; prebiotics are the fibres that feed them; butyrate is a postbiotic — a metabolite those bacteria produce. Taking butyrate directly skips the microbiome step entirely, which is either the point or the problem depending on your view. See our Akkermansia guide for the probiotic side.
For salt forms, it helps address the central problem. A large proportion of oral sodium butyrate is absorbed in the upper gastrointestinal tract before reaching the lower intestine and colon, which is exactly why enteric-coated and slow-release formulations exist [1]. Tributyrin's ester structure serves a similar purpose without a coating.
The butyrate itself usually is, but capsule shells frequently are not — gelatin is common in this category. Check the "other ingredients" list before buying, and see vegan longevity supplements for the full audit of hidden animal-derived components.
For most people, more dietary fibre — which is food, not a supplement, and has population-level outcome evidence behind it [2,5]. If you want a product, match it to your actual situation: butyrate has its best case in IBS [1], probiotics work strain-by-strain for specific conditions, and neither is a general wellness purchase. Our view on this category-wide is in longevity supplements that probably don't work.
Medical disclaimer
This article is for general information and does not constitute medical advice, diagnosis or treatment. Food supplements are not a substitute for a varied, balanced diet and a healthy lifestyle, and should not be used to treat or prevent disease. Butyrate supplements are not a treatment for inflammatory bowel disease, irritable bowel syndrome or any other diagnosed condition, and should not replace prescribed treatment. Persistent changes in bowel habit, blood in the stool, unexplained weight loss or persistent abdominal pain require prompt medical assessment rather than self-supplementation. Always consult a qualified healthcare professional before starting any new supplement, particularly if you take prescription medication, have a gastrointestinal condition, are on a sodium-restricted diet, or are pregnant or breastfeeding. Reviewed for medical accuracy by Dr Zeeshan Afzal. See the full Welzo medical disclaimer.
All product photography in this article is owned by Welzo and served from the Welzo media library. Prices and availability correct at the time of publication and subject to change.
Ocijenjeno izvrsno s 26,523+ recenzija
100% jamstvo povratka novca
Naše jamstvo povrata novca osigurava da primite svoje predmete ili dobijete potpuni povrat novca.
